Nanomedicine and clinical diagnostics part I: applications in conventional imaging (MRI, X-ray/CT, and ultrasound)
Authors:
- 11 December 2024
- journal article
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (2) , 167-182
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- Bismuth nanomaterials as contrast agents for radiography and computed tomography imaging and their quality/safety considerationsWIREs Nanomedicine and Nanobiotechnology, 2022
- Nanoparticles in the clinic: An update post COVID‐19 vaccinesBioengineering & Translational Medicine, 2021
- Fundamentals and applications of nanoparticles for ultrasound‐based imaging and therapyNano Select, 2020
- Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and ProspectivesAdvanced Materials, 2020
- Nanoparticle contrast agents for X‐ray imaging applicationsWIREs Nanomedicine and Nanobiotechnology, 2020
- Integration of gadolinium in nanostructure for contrast enhanced‐magnetic resonance imagingWIREs Nanomedicine and Nanobiotechnology, 2019
- Breaking the Depth Dependence by Nanotechnology‐Enhanced X‐Ray‐Excited Deep Cancer TheranosticsAdvanced Materials, 2019
- Recombinantly expressed gas vesicles as nanoscale contrast agents for ultrasound and hyperpolarized MRIAIChE Journal, 2018
- Tunable Performance of Manganese Oxide Nanostructures as MRI Contrast AgentsChemistry – A European Journal, 2017
- Nanoparticles in the clinicBioengineering & Translational Medicine, 2016